IThe smaller stock measure has gained nearly 33% in that span, more than double the rise in the broader benchmark, with the outperformance becoming particularly pronounced amid the recent market chill.
MUMBAI: The outperformance of India’s mid-cap stocks over their larger peers since the coronavirus pandemic engulfed global markets may take a breather, according to some investors.
Fund managers at Star Health & Allied Insurance Co and Smartsun Capital Pte Ltd said they are currently avoiding mid caps based on global economic cues and valuations.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
